Founded in 1975 as the all Union Research Institute of Applied Enzimology, currently,  the Institute of Biotechnology is mainly involved in research and training in the fields of biotechnology and molecular biology, including research and development of recombinant biomedical proteins, genetic and molecular studies of restriction modification phenomenon, developing of viruses diagnostics, epigenetic study of small RNA, drug design and synthesis, bioinformatics.

News

Spausdinti

The success of the Institute of Biotechnology: the EU FP7 MoBiLi project

The scientists from the Institute of Biotechnology (IBT) are proud of their success of receiving an EU support. The project "Strengthening and Sustaining the European Perspectives of Molecular Biotechnology in Lithuania" MoBiLi (total budget 1.6 mln euro) has been selected from many applications for funding by the EU FP7 Capacities programme.
The latter coordination and support action (Research Potential Call FP7-REGPOT-2009-1) was very competitive: 312 proposals were received by the Commission, 135 proposals had passed evaluation step and only 16 were selected for funding (MoBiLi ranked 7-th among the selected projects). Total budget of the project MoBiLi is 1.6 mln. euro, project length is 3.5 years (2010-2013).

Purpose of the project is to transfer the knowledge on achievements in molecular biology and their application in biomedicine as well as to gain new experience in this multidisciplinary subject by extending an international collaboration with the major research centers in Europe.

The project will support a human capital building for research and technological development (RTD) in the field of state-of-the-art molecular biotechnology. For this purpose, a series of post-doc fellowships, short- and long-term outgoing and incoming training visits and trips to the international scientific conferences will be arranged; seminars at the IBT by the leading scientists from foreign institutions will be held. New equipment for IBT laboratories will be acquired to upgrade and modernise research infrastructure in line with emerging thematic priorities in the field.

The project will promote forming an image of scientists' carrier, strengthening of scientific potential and formation of the policy of science in Lithuania. Collaboration of IBT with the core project partners, the well-recognized European research centers as the European Molecular Biology Laboratory (Germany and UK), Karolinska institutet (Sweden), Justus Liebig University Giessen (Germany), University of Edinburgh (UK) and the Swiss Institute of Bioinformatics (Switzerland) will implement the task of building IBT as a significant player in the European Research Area.

Episodes from MoBiLi Kickoff Meeting March 25-27th, 2010: